Roche Diagnostics cobas™ Liat SARS-CoV-2, Influenza A/B and RSV Control Kit
Manufacturer: Roche Diagnostics
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 21-200-318-Each-of-1 | In Stock | ₹ 16,085.28 |
21-200-318 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 16,085.28
GST (18%): ₹ 2,895.35
Total Price: ₹ 18,980.63
Content And Storage
20 Tests/Kit; Store at 2°C to 8°C
CPT Code
87637
Clia Complexity
Waived (EUA)
Detection Method
Nucleic Acid RT-PCR
Format
Kit
Sensitivity
Influenza A, B, RSV = 100% positive agreement; SARS-CoV-2=96.7% positive agreement
Disposable
Single-use
For Use With (Equipment)
Used with the cobas™ liat analyzer
Quantity
1
Test Time
20 min.
Dimensions (L x W x H)
10.6 x 6.5 x 5.4 in.
Form
Ready-to-Use (RTU)
Control Sets
integrated sample processing control, positive and negative controls
CE Marker
Yes
Detectable Analytes
SARS-CoV-2, Influenza A and B, Rubella Virus Antibodies
DoA Calibrators
No
Sample Type
Nasaopharyngeal or anterior nasal
Type
Test
For Use With (Application)
Detection of SARS-CoV-2, Influenza A/B, and RSV
Product Line
cobas™
Specificity
SARS-CoV-2=96.7% negative agreement; Influenza A = 98.1% negative agreement; Influenza B = 97.7% negative agreement; RSV = 97.2% negative agreement
Analysis Time
20 min.
Weight (English)
2.4 lb.
Related Products
Description
- The cobas™ liat SARS-CoV-2, Influenza A/B and RSV control kit for use with the cobas liat SARS-CoV-2, Influenza A/B and RSV assay
- Control kit includes three positive and three negative controls.
SAFETY INFORMATION
- ShelfLife : 12 Months